1. Home
  2. STGW vs SRDX Comparison

STGW vs SRDX Comparison

Compare STGW & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STGW
  • SRDX
  • Stock Information
  • Founded
  • STGW 1980
  • SRDX 1979
  • Country
  • STGW United States
  • SRDX United States
  • Employees
  • STGW N/A
  • SRDX N/A
  • Industry
  • STGW
  • SRDX Medical/Dental Instruments
  • Sector
  • STGW
  • SRDX Health Care
  • Exchange
  • STGW Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • STGW 662.6M
  • SRDX 562.6M
  • IPO Year
  • STGW N/A
  • SRDX 1998
  • Fundamental
  • Price
  • STGW $6.63
  • SRDX $37.50
  • Analyst Decision
  • STGW Strong Buy
  • SRDX Hold
  • Analyst Count
  • STGW 5
  • SRDX 4
  • Target Price
  • STGW $8.50
  • SRDX $43.00
  • AVG Volume (30 Days)
  • STGW 345.5K
  • SRDX 282.8K
  • Earning Date
  • STGW 02-25-2025
  • SRDX 01-30-2025
  • Dividend Yield
  • STGW N/A
  • SRDX N/A
  • EPS Growth
  • STGW N/A
  • SRDX N/A
  • EPS
  • STGW 0.00
  • SRDX N/A
  • Revenue
  • STGW $2,707,403,000.00
  • SRDX $126,078,000.00
  • Revenue This Year
  • STGW $13.05
  • SRDX $13.75
  • Revenue Next Year
  • STGW N/A
  • SRDX $13.67
  • P/E Ratio
  • STGW $2,390.91
  • SRDX N/A
  • Revenue Growth
  • STGW 4.92
  • SRDX N/A
  • 52 Week Low
  • STGW $4.88
  • SRDX $25.17
  • 52 Week High
  • STGW $8.18
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • STGW 49.63
  • SRDX 41.52
  • Support Level
  • STGW $5.81
  • SRDX $35.97
  • Resistance Level
  • STGW $6.57
  • SRDX $37.08
  • Average True Range (ATR)
  • STGW 0.23
  • SRDX 0.93
  • MACD
  • STGW 0.05
  • SRDX -0.23
  • Stochastic Oscillator
  • STGW 92.13
  • SRDX 50.28

About STGW Stagwell Inc.

Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; Communications Network and other. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Share on Social Networks: